Odyssey raises more than $300M as biotech goes public in IPO
Odyssey Therapeutics pulled together $279 million from its initial public offering, the autoimmune disease drug developer said Thursday night. With its IPO now priced, Odyssey is slated to begin trading on the Nasdaq on Friday ...
ORIGINAL SOURCE →via Endpoint News
ADVERTISEMENT
⚡ STAY AHEAD
Events like this, convergence-verified across 689 sources, land in your inbox every Sunday. Free.
GET THE SUNDAY BRIEFING →RELATED · finance
- [FINANCE] African women urged to harness green economy potential
- [FINANCE] China marks milestone with first home-certified airship pilots
- [FINANCE] Runway Growth Q1 2026 slides: earnings miss amid SWK integration - Investing.com
- [FINANCE] Trump Says Cease-Fire Intact After Trade of Attacks in Strait of Hormuz
- [FINANCE] Sumitomo Mitsui Trust Bank targeting $500 million for new aircraft lease fund
- [FINANCE] React Form Handling: Debounced Validation, Auto-Save Drafts, and Controlled Inputs